Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B5,7 | Lung | Primary cancer | 2,625 | Tumor/Malignant | 35.8% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__86_B5,9 | Lung | Primary cancer | 190 | Immune | 53.2% | 0.74 | 0.48 |
| NSCLC_38242124__IMC__86_B6,1 | Lung | Primary cancer | 2,720 | Tumor/Malignant | 86.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B6,10 | Lung | Primary cancer | 2,835 | Tumor/Malignant | 56.4% | 0.92 | 0.22 |
| NSCLC_38242124__IMC__86_B6,11 | Lung | Primary cancer | 2,424 | Stromal | 33.8% | 0.40 | 0.87 |
| NSCLC_38242124__IMC__86_B6,12 | Lung | Primary cancer | 19 | Tumor/Malignant | 52.6% | 0.80 | 0.55 |
| NSCLC_38242124__IMC__86_B6,13 | Lung | Primary cancer | 3,677 | Tumor/Malignant | 75.6% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__86_B6,14 | Lung | Primary cancer | 1,447 | Stromal | 29.2% | 0.36 | 1.01 |
| NSCLC_38242124__IMC__86_B6,2 | Lung | Primary cancer | 3,223 | Tumor/Malignant | 57.1% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__86_B6,3 | Lung | Primary cancer | 3,951 | Immune | 32.3% | 0.91 | 0.27 |
| NSCLC_38242124__IMC__86_B6,4 | Lung | Primary cancer | 918 | Stromal | 33.9% | 0.74 | 0.55 |
| NSCLC_38242124__IMC__86_B6,5 | Lung | Primary cancer | 1,799 | Tumor/Malignant | 50.4% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__86_B6,6 | Lung | Primary cancer | 3,212 | Tumor/Malignant | 28.7% | 0.35 | 0.98 |
| NSCLC_38242124__IMC__86_B6,7 | Lung | Primary cancer | 2,833 | Tumor/Malignant | 57.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__86_B6,8 | Lung | Primary cancer | 36 | Tumor/Malignant | 86.1% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__86_B6,9 | Lung | Primary cancer | 1,140 | Stromal | 28.7% | 0.56 | 0.90 |
| NSCLC_38242124__IMC__86_B7,1 | Lung | Primary cancer | 2,196 | Tumor/Malignant | 48.0% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__86_B7,10 | Lung | Primary cancer | 2,888 | Tumor/Malignant | 36.6% | 0.92 | 0.29 |
| NSCLC_38242124__IMC__86_B7,11 | Lung | Primary cancer | 51 | Other | 64.7% | 0.55 | 0.60 |
| NSCLC_38242124__IMC__86_B7,12 | Lung | Primary cancer | 4,398 | Immune | 35.7% | 0.92 | 0.25 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B5,7 | Lung | Primary cancer | 2,625 | Tumor/Malignant | 36.0% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__86_B5,9 | Lung | Primary cancer | 190 | Tumor/Malignant | 63.2% | 0.27 | 0.76 |
| NSCLC_38242124__IMC__86_B6,1 | Lung | Primary cancer | 2,720 | Tumor/Malignant | 67.2% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__86_B6,10 | Lung | Primary cancer | 2,835 | Tumor/Malignant | 39.5% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__86_B6,11 | Lung | Primary cancer | 2,424 | Stromal | 31.5% | 0.40 | 0.90 |
| NSCLC_38242124__IMC__86_B6,12 | Lung | Primary cancer | 19 | Tumor/Malignant | 52.6% | 0.80 | 0.55 |
| NSCLC_38242124__IMC__86_B6,13 | Lung | Primary cancer | 3,677 | Tumor/Malignant | 57.5% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__86_B6,14 | Lung | Primary cancer | 1,447 | Stromal | 25.6% | 0.38 | 1.05 |
| NSCLC_38242124__IMC__86_B6,2 | Lung | Primary cancer | 3,223 | Tumor/Malignant | 57.6% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__86_B6,3 | Lung | Primary cancer | 3,951 | Lymphoid | 24.6% | 0.56 | 0.85 |
| NSCLC_38242124__IMC__86_B6,4 | Lung | Primary cancer | 918 | Stromal | 27.2% | 0.78 | 0.52 |
| NSCLC_38242124__IMC__86_B6,5 | Lung | Primary cancer | 1,799 | Tumor/Malignant | 72.4% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__86_B6,6 | Lung | Primary cancer | 3,212 | Tumor/Malignant | 24.3% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__86_B6,7 | Lung | Primary cancer | 2,833 | Tumor/Malignant | 46.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_B6,8 | Lung | Primary cancer | 36 | Tumor/Malignant | 86.1% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__86_B6,9 | Lung | Primary cancer | 1,140 | Stromal | 27.8% | 0.54 | 0.90 |
| NSCLC_38242124__IMC__86_B7,1 | Lung | Primary cancer | 2,196 | Tumor/Malignant | 39.3% | 0.69 | 0.61 |
| NSCLC_38242124__IMC__86_B7,10 | Lung | Primary cancer | 2,888 | Tumor/Malignant | 29.0% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__86_B7,11 | Lung | Primary cancer | 51 | Other | 64.7% | 0.55 | 0.62 |
| NSCLC_38242124__IMC__86_B7,12 | Lung | Primary cancer | 4,398 | Myeloid | 33.0% | 0.91 | 0.27 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B5,7 | Lung | Primary cancer | 2,625 | Tumor/Malignant cell | 35.7% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__86_B5,9 | Lung | Primary cancer | 190 | B cell | 55.8% | 0.39 | 0.73 |
| NSCLC_38242124__IMC__86_B6,1 | Lung | Primary cancer | 2,720 | Tumor/Malignant cell | 87.0% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B6,10 | Lung | Primary cancer | 2,835 | Tumor/Malignant cell | 56.8% | 0.91 | 0.22 |
| NSCLC_38242124__IMC__86_B6,11 | Lung | Primary cancer | 2,424 | Tumor/Malignant cell | 26.9% | 0.92 | 0.32 |
| NSCLC_38242124__IMC__86_B6,12 | Lung | Primary cancer | 19 | Tumor/Malignant cell | 52.6% | 0.80 | 0.55 |
| NSCLC_38242124__IMC__86_B6,13 | Lung | Primary cancer | 3,677 | Tumor/Malignant cell | 76.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__86_B6,14 | Lung | Primary cancer | 1,447 | Fibroblast | 30.4% | 0.61 | 0.80 |
| NSCLC_38242124__IMC__86_B6,2 | Lung | Primary cancer | 3,223 | Tumor/Malignant cell | 60.8% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__86_B6,3 | Lung | Primary cancer | 3,951 | T cell | 35.8% | 0.48 | 0.93 |
| NSCLC_38242124__IMC__86_B6,4 | Lung | Primary cancer | 918 | Fibroblast | 52.3% | 0.87 | 0.36 |
| NSCLC_38242124__IMC__86_B6,5 | Lung | Primary cancer | 1,799 | Tumor/Malignant cell | 76.6% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__86_B6,6 | Lung | Primary cancer | 3,212 | Tumor/Malignant cell | 28.6% | 0.89 | 0.35 |
| NSCLC_38242124__IMC__86_B6,7 | Lung | Primary cancer | 2,833 | Tumor/Malignant cell | 57.5% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__86_B6,8 | Lung | Primary cancer | 36 | Tumor/Malignant cell | 86.1% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__86_B6,9 | Lung | Primary cancer | 1,140 | Fibroblast | 34.6% | 0.72 | 0.68 |
| NSCLC_38242124__IMC__86_B7,1 | Lung | Primary cancer | 2,196 | Tumor/Malignant cell | 52.0% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__86_B7,10 | Lung | Primary cancer | 2,888 | Tumor/Malignant cell | 36.3% | 0.92 | 0.29 |
| NSCLC_38242124__IMC__86_B7,11 | Lung | Primary cancer | 51 | Other | 64.7% | 0.55 | 0.62 |
| NSCLC_38242124__IMC__86_B7,12 | Lung | Primary cancer | 4,398 | Granulocyte | 43.8% | 0.83 | 0.38 |